89 related articles for article (PubMed ID: 8334560)
41. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal.
Faggiano A; Milone F; Ramundo V; Chiofalo MG; Ventre I; Giannattasio R; Severino R; Lombardi G; Colao A; Pezzullo L
J Clin Endocrinol Metab; 2010 Sep; 95(9):E32-6. PubMed ID: 20534767
[TBL] [Abstract][Full Text] [Related]
42. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
[TBL] [Abstract][Full Text] [Related]
43. Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis.
Schuetz M; Beheshti M; Oezer S; Novotny C; Paul M; Hofmann A; Bieglmayer C; Niederle B; Kletter K; Dudczak R; Karanikas G; Pirich C
Anticancer Res; 2006; 26(1B):723-7. PubMed ID: 16739344
[TBL] [Abstract][Full Text] [Related]
44. Surgical treatment of medullary thyroid carcinoma in a thirteen-year-old girl with MEN 2B.
Tisell LE; Jansson S
Henry Ford Hosp Med J; 1989; 37(3-4):157-9. PubMed ID: 2576953
[TBL] [Abstract][Full Text] [Related]
45. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma.
O'Dorisio TM; Falko JM; Cataland S; Almoney RW; George JM; Mazzaferri EL; Reynolds JC
J Clin Endocrinol Metab; 1982 Apr; 54(4):798-802. PubMed ID: 7061688
[TBL] [Abstract][Full Text] [Related]
46. [Medullary thyroid cancer: review of 28 patients].
Pulgar B D; Jans B J; Petric G M; León R A; Camus A M; Goñi E I; Domínguez C F; Droppelmann M N; Claure S R; González D H
Rev Med Chil; 2013 Nov; 141(11):1395-401. PubMed ID: 24718465
[TBL] [Abstract][Full Text] [Related]
47. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
48. [Value of calcitonin determination in the evaluation of completeness of thyroidectomy in medullary carcinoma of the thyroid gland].
Wasylewski A; Skrzypek J; Kokot F; Sledziński Z
Endokrynol Pol; 1981; 32(3):239-44. PubMed ID: 7308165
[No Abstract] [Full Text] [Related]
49. Spontaneous Deceleration and Acceleration of Growth Rate in Medullary Thyroid Carcinomas Suggested by Changes in Calcitonin Doubling Times Over Long-Term Surveillance.
Miyauchi A; Kudo T; Kihara M; Oda H; Ito Y; Miya A
World J Surg; 2019 Feb; 43(2):504-512. PubMed ID: 30229381
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma.
Pyke CM; Hay ID; Goellner JR; Bergstralh EJ; van Heerden JA; Grant CS
Surgery; 1991 Dec; 110(6):964-70; discussion 970-1. PubMed ID: 1745984
[TBL] [Abstract][Full Text] [Related]
51. Clinical experience of medullary thyroid carcinoma in Chang Gung Memorial Hospital.
Ho C; Lin JD; Huang YY; Huang HS; Huang BY; Hsueh C
Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):142-8. PubMed ID: 8828256
[TBL] [Abstract][Full Text] [Related]
52. Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients' carcinoma death.
Ito Y; Miyauchi A; Kihara M; Kudo T; Miya A
Endocr J; 2016 Jul; 63(7):663-7. PubMed ID: 27097545
[TBL] [Abstract][Full Text] [Related]
53. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
Palmer BV; Harmer CL; Shaw HJ
Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
[TBL] [Abstract][Full Text] [Related]
54. Medullary thyroid carcinoma detected by serum calcitonin assay.
Block MA; Jackson CE; Tashjian AH
Arch Surg; 1972 Apr; 104(4):579-86. PubMed ID: 5013799
[No Abstract] [Full Text] [Related]
55. Prevalence of hypercalcitoninemia in patients on maintenance dialysis referred to kidney transplantation.
Akan B; Böhmig G; Sunder-Plassmann G; Borchhardt KA
Clin Nephrol; 2009 May; 71(5):538-42. PubMed ID: 19473614
[TBL] [Abstract][Full Text] [Related]
56. Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. A nationwide study in Sweden. The Swedish MTC Study Group.
Bergholm U; Adami HO; Auer G; Bergström R; Bäckdahl M; Grimelius L; Hansson G; Ljungberg O; Wilander E
Cancer; 1989 Jul; 64(1):135-42. PubMed ID: 2731109
[TBL] [Abstract][Full Text] [Related]
57. Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma.
Modigliani E; Cohen R; Joannidis S; Siame-Mourot C; Guliana JM; Charpentier G; Cassuto D; Bentata Pessayre M; Tabarin A; Roger P
Clin Endocrinol (Oxf); 1992 Feb; 36(2):183-6. PubMed ID: 1568350
[TBL] [Abstract][Full Text] [Related]
58. Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.
Miyauchi A; Onishi T; Morimoto S; Takai S; Matsuzuka F; Kuma K; Maeda M; Kumahara Y
Ann Surg; 1984 Apr; 199(4):461-6. PubMed ID: 6712322
[TBL] [Abstract][Full Text] [Related]
59. Nuclear DNA content and survival in medullary thyroid carcinoma. Swedish Medullary Thyroid Cancer Study Group.
Ekman ET; Bergholm U; Bäckdahl M; Adami HO; Bergström R; Grimelius L; Auer G
Cancer; 1990 Feb; 65(3):511-7. PubMed ID: 2297642
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels.
Miyauchi A; Matsuzuka F; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
World J Surg; 1988 Oct; 12(5):610-5. PubMed ID: 3245215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
